Top Markets
Coin of the day
Artemis Therapeutics Inc. Artemis Therapeutics Inc.

Artemis Therapeutics Inc.

ATMS
Rank in Stocks #24862
Artemis Therapeutics Inc. currently lacks substantial business operations.... Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat severe and life-threatening infectious diseases. It is a subsidiary of Tonak Ltd.
Share Price
$0.498
Last synced: 2023-05-25
Market Cap
$55.79M
Change (1 day)
-73.65%
Change (1 year)
0.00%
Country
US
Trade Artemis Therapeutics Inc. (ATMS)
Operating Margin for Artemis Therapeutics Inc. (ATMS)
Operating Margin as of 2026 TTM: 0.00%
According to Artemis Therapeutics Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Artemis Therapeutics Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
US
0.00% -
US
0.00% -
CN
0.00% -
US
0.00% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.